A re‐examination of the epstein‐barr virus carrier state in healthy seropositive individuals
- 15 January 1985
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 35 (1) , 35-42
- https://doi.org/10.1002/ijc.2910350107
Abstract
A panel of 24 healthy seropositive donors have been followed prospectively over a period of 15 months and monitored (1) for the level of EB virus shedding in the throat by means of a sensitive cord‐blood transformation assay; (2) for the level of virus‐infected B cells in the blood via a new in vitro protocol where “spontaneous transformation” can be seen to titrate against input cell number; (3) for anti‐EB viral antibody titres and (4) for the prevailing level of virus‐specific memory T cells in the circulation. Six donors shed easily detectable levels of EB virus into throat washings on every occasion of testing, whilst 16 other donors shed lower levels of virus detectable in throat washings on a majority (10 donors) or on a minority (6 donors) of test occasions; only 2/24 donors gave no evidence of virus shedding at any time. There was a direct relationship between the EB virus shedder status of an individual (i. e., the level of virus replication in the pharynx) and the number of infected B cells present in the circulation. These results indicate that chronic, usually low‐grade, replication of the virus at some permissive site in the oro‐and/or naso‐pharynx is very often a stable accompaniment of the asymptomatic EB virus carrier state, and may indeed be essential for the long‐term maintenance of that state.This publication has 28 references indexed in Scilit:
- In vitro analysis of the epstein‐barr virus: Host balance in long‐term renal allograft recipientsInternational Journal of Cancer, 1985
- Epstein–Barr Virus Replication in Oropharyngeal Epithelial CellsNew England Journal of Medicine, 1984
- Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell linesNature, 1981
- Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. I. Complete regression of virus‐induced transformation in cultures of seropositive donor leukocytesInternational Journal of Cancer, 1978
- Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious MononucleosisNew England Journal of Medicine, 1977
- Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell linesInternational Journal of Cancer, 1973
- Leukocyte-Transforming Agent: Prolonged Excretion by Patients with Mononucleosis and Excretion by Normal IndividualsThe Journal of Infectious Diseases, 1973
- ORAL EXCRETION OF EPSTEIN-BARR VIRUS BY HEALTHY SUBJECTS AND PATIENTS WITH INFECTIOUS MONONUCLEOSISThe Lancet, 1972
- Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes‐like virusInternational Journal of Cancer, 1968
- Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt CellsScience, 1967